Moscow dismissed Macron’s nuclear deterrent offer as “extremely confrontational,” saying the remarks reflected Paris’ ...

This €1.6 Million financing will allow MSInsight to finalize MSIcare’s technological development, demonstrate its performance in various types of cancer, and initiate the regulatory clinical ...